DNAGinkgo Bioworks Holdings, Inc.
$11.34-23% 1Y
$11.34
$5.4852 weeks$16.09
The financials
Ginkgo Bioworks Holdings, Inc. by the numbers
Ginkgo Bioworks Holdings, Inc. (DNA) reported revenue of $20M in Q2 2026 (quarter ended Jun 30, 2026), down 48% from the same quarter a year earlier. That came with a gross margin of 91% and net loss of $47M. For the full year FY2025, revenue was $170M (−25% year on year) and net income −$313M. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $20M | $39M | −48% |
| Gross profit | $18M | $34M | −45% |
| Operating income | −$59M | −$58M | n/a |
| Net income | −$47M | −$60M | n/a |
| Diluted EPS | n/a | −$1.10 | n/a |